Wednesday, October 05, 2022 4:34:12 PM
10/05/22 16:07:47 10.81 10.55 11.45 1,000
10/05/22 16:01:17 10.81 10.55 11.45 4,400
10/05/22 16:00:11 10.81 10.55 11.45 2,400
10/05/22 16:00:11 10.81 10.55 11.45 4,400
10/05/22 16:00:01 10.81 10.75 10.90 97,200
10/05/22 16:00:01 10.80 10.75 10.90 1,093
10/05/22 16:00:00 10.79 10.75 10.90 93,319
10/05/22 15:59:58 10.81 10.79 10.80 1,880
10/05/22 15:59:56 10.81 10.78 10.81 2,451
10/05/22 15:59:52 10.80 10.80 10.82 1,431
10/05/22 15:54:50 10.81 10.82 10.83 2,236
10/05/22 15:54:40 10.85 10.84 10.86 1,566
10/05/22 15:35:48 10.8501 10.85 10.87 1,000
10/05/22 15:35:48 10.85 10.85 10.87 1,500
10/05/22 15:35:48 10.85 10.85 10.87 1,400
10/05/22 15:33:06 10.85 10.85 10.87 7,900
10/05/22 15:32:44 10.8501 10.85 10.87 1,400
10/05/22 15:31:28 10.85 10.83 10.85 2,000
10/05/22 15:30:48 10.84 10.83 10.84 2,000
10/05/22 15:29:32 10.8001 10.80 10.82 3,000
10/05/22 15:26:32 10.80 10.79 10.81 1,000
10/05/22 15:24:51 10.83 10.81 10.82 3,100
10/05/22 15:19:06 10.8046 10.80 10.81 1,500
10/05/22 15:12:55 10.74 10.73 10.75 1,000
10/05/22 14:51:31 10.75 10.75 10.77 1,400
10/05/22 14:49:40 10.7729 10.76 10.78 1,000
10/05/22 14:05:39 10.7691 10.76 10.77 1,000
10/05/22 14:00:56 10.7295 10.72 10.74 2,000
10/05/22 13:35:25 10.74 10.73 10.75 1,400
10/05/22 13:34:20 10.77 10.78 10.80 1,100
10/05/22 13:32:28 10.8007 10.80 10.82 4,000
10/05/22 13:30:25 10.85 10.85 10.86 1,700
10/05/22 12:56:12 10.83 10.84 10.86 1,000
10/05/22 12:45:50 10.8202 10.82 10.85 1,700
10/05/22 12:44:27 10.81 10.79 10.81 3,100
10/05/22 12:27:41 10.7275 10.72 10.74 1,000
10/05/22 12:16:16 10.7601 10.76 10.78 1,900
10/05/22 11:17:55 10.76 10.76 10.78 3,200
10/05/22 11:16:51 10.76 10.75 10.76 2,700
10/05/22 11:02:26 10.72 10.70 10.72 1,200
10/05/22 11:02:08 10.7001 10.70 10.72 5,000
10/05/22 10:57:31 10.6153 10.60 10.62 1,100
10/05/22 10:55:23 10.6256 10.61 10.64 1,000
10/05/22 10:52:38 10.605 10.59 10.62 1,000
10/05/22 10:43:22 10.53 10.51 10.54 1,200
10/05/22 10:29:59 10.4676 10.45 10.48 2,000
10/05/22 10:25:24 10.5007 10.49 10.52 1,000
10/05/22 10:05:56 10.52 10.53 10.56 5,000
10/05/22 10:04:46 10.55 10.55 10.57 1,200
10/05/22 10:04:46 10.55 10.55 10.57 1,700
10/05/22 09:56:58 10.5996 10.57 10.60 2,500
10/05/22 09:55:08 10.5797 10.57 10.60 1,000
10/05/22 09:49:23 10.49 10.52 10.57 1,000
10/05/22 09:49:23 10.52 10.52 10.57 1,500
10/05/22 09:46:56 10.5301 10.53 10.56 2,000
10/05/22 09:43:38 10.594 10.58 10.62 1,000
10/05/22 09:43:32 10.60 10.60 10.63 2,700
10/05/22 09:43:32 10.60 10.60 10.63 2,000
10/05/22 09:43:11 10.64 10.66 10.70 1,100
10/05/22 09:38:08 10.6575 10.65 10.70 1,500
10/05/22 09:38:08 10.661 10.65 10.70 1,200
10/05/22 09:37:24 10.69 10.72 10.76 1,100
10/05/22 09:37:24 10.69 10.72 10.76 1,300
10/05/22 09:35:55 10.76 10.73 10.79 2,000
10/05/22 09:35:03 10.77 10.73 10.80 2,900
10/05/22 09:33:28 10.7156 10.71 10.81 1,300
10/05/22 09:32:25 10.74 10.73 10.79 1,033
10/05/22 09:31:22 10.72 10.70 10.74 1,116
10/05/22 09:30:00 10.70 10.66 10.83 4,600
10/04/22 16:15:29 10.89 10.29 10.93 4,000
10/04/22 16:06:45 10.89 10.29 10.93 3,900
10/04/22 16:02:07 10.89 10.29 10.93 8,100
10/04/22 16:01:27 10.89 10.29 10.93 2,500
10/04/22 16:00:44 10.89 10.29 10.93 1,000
10/04/22 16:00:09 10.89 10.29 11.56 1,800
10/04/22 16:00:09 10.89 10.29 11.56 6,600
10/04/22 16:00:01 10.89 10.86 10.90 1,531
10/04/22 16:00:00 10.90 10.86 10.90 205,604
10/04/22 15:59:46 10.8905 10.89 10.90 1,200
10/04/22 15:59:46 10.89 10.89 10.90 1,750
10/04/22 15:59:42 10.90 10.89 10.90 1,094
10/04/22 15:59:13 10.87 10.86 10.87 1,000
10/04/22 15:59:11 10.8611 10.86 10.87 1,500
10/04/22 15:58:52 10.86 10.85 10.86 1,000
10/04/22 15:58:33 10.86 10.85 10.86 1,200
10/04/22 15:58:07 10.8401 10.84 10.85 5,000
10/04/22 15:57:49 10.85 10.84 10.85 1,500
10/04/22 15:57:10 10.85 10.84 10.85 1,500
10/04/22 15:57:04 10.855 10.85 10.86 1,000
10/04/22 15:57:04 10.86 10.86 10.87 2,900
10/04/22 15:56:56 10.88 10.87 10.88 2,300
10/04/22 15:56:47 10.88 10.86 10.87 1,412
10/04/22 15:55:45 10.7904 10.79 10.80 1,100
10/04/22 15:54:40 10.79 10.78 10.81 7,190
10/04/22 15:53:58 10.78 10.78 10.79 1,200
10/04/22 15:50:16 10.75 10.73 10.75 3,400
10/04/22 15:41:43 10.7111 10.71 10.73 1,200
10/04/22 15:30:04 10.75 10.77 10.80 1,228
10/04/22 15:29:06 10.7421 10.73 10.75 1,000
10/04/22 15:28:24 10.7592 10.75 10.76 1,000
10/04/22 15:26:23 10.8001 10.80 10.82 5,000
10/04/22 15:17:40 10.8001 10.80 10.82 5,000
10/04/22 15:09:23 10.8083 10.79 10.81 1,000
10/04/22 15:04:57 10.8119 10.81 10.83 1,000
10/04/22 15:01:08 10.78 10.78 10.81 1,000
10/04/22 15:00:50 10.78 10.76 10.78 1,000
10/04/22 14:59:43 10.76 10.75 10.76 2,800
10/04/22 14:48:28 10.7501 10.75 10.77 1,000
10/04/22 14:28:54 10.69 10.68 10.70 1,800
10/04/22 13:50:08 10.62 10.60 10.63 5,000
10/04/22 13:31:05 10.55 10.54 10.55 1,249
10/04/22 13:31:04 10.50 10.48 10.49 30,900
10/04/22 13:31:04 10.50 10.48 10.49 1,800
10/04/22 13:31:04 10.49 10.48 10.49 1,000
10/04/22 13:30:40 10.49 10.48 10.49 1,000
10/04/22 13:28:08 10.49 10.48 10.49 1,000
10/04/22 13:26:49 10.4899 10.47 10.49 1,000
10/04/22 13:23:31 10.49 10.48 10.49 1,000
10/04/22 13:23:30 10.49 10.48 10.49 1,000
10/04/22 13:23:30 10.49 10.48 10.49 1,100
10/04/22 13:23:24 10.49 10.47 10.49 1,100
10/04/22 13:23:24 10.49 10.47 10.49 1,100
10/04/22 13:23:24 10.4899 10.47 10.49 1,000
10/04/22 13:21:29 10.50 10.50 10.52 1,600
10/04/22 13:21:29 10.50 10.50 10.52 29,400
10/04/22 13:15:01 10.53 10.53 10.55 1,100
10/04/22 12:45:07 10.67 10.66 10.68 3,000
10/04/22 11:40:53 10.7698 10.75 10.77 5,000
10/04/22 11:33:16 10.7701 10.77 10.80 3,300
10/04/22 11:30:11 10.80 10.74 10.76 3,500
10/04/22 10:55:23 10.8093 10.78 10.81 2,000
10/04/22 10:52:52 10.81 10.81 10.82 1,800
10/04/22 10:52:02 10.76 10.76 10.79 1,400
10/04/22 10:51:44 10.7711 10.77 10.80 1,500
10/04/22 10:50:09 10.75 10.73 10.75 3,400
10/04/22 10:50:09 10.75 10.73 10.75 1,400
10/04/22 10:48:29 10.70 10.67 10.70 1,100
10/04/22 10:35:31 10.58 10.58 10.59 1,700
10/04/22 10:35:31 10.58 10.58 10.59 2,900
10/04/22 10:27:07 10.63 10.61 10.62 1,000
10/04/22 10:23:55 10.63 10.62 10.64 1,000
10/04/22 10:17:45 10.6989 10.67 10.70 1,000
10/04/22 10:16:17 10.6475 10.60 10.65 2,500
10/04/22 10:09:41 10.70 10.67 10.70 4,000
10/04/22 10:02:18 10.6747 10.65 10.69 1,000
10/04/22 09:59:22 10.6223 10.62 10.68 1,600
10/04/22 09:50:15 10.72 10.71 10.75 2,000
10/04/22 09:40:22 10.79 10.76 10.82 2,500
10/04/22 09:40:00 10.7818 10.78 10.81 5,000
10/04/22 09:34:51 10.80 10.75 10.80 1,400
10/04/22 09:34:43 10.7548 10.74 10.80 1,000
10/04/22 09:34:16 10.8001 10.80 10.83 5,000
10/04/22 09:33:50 10.82 10.78 10.82 1,000
10/04/22 09:33:29 10.7714 10.74 10.82 2,000
10/04/22 09:31:57 10.77 10.68 10.77 2,500
10/04/22 09:31:30 10.6801 10.68 10.77 1,000
10/04/22 09:31:14 10.7079 10.62 10.76 1,000
10/04/22 09:30:14 10.70 10.64 10.76 1,000
10/04/22 09:30:00 10.68 10.65 10.77 5,300
Recent AVXL News
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
- Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference • GlobeNewswire Inc. • 11/26/2025 12:30:00 PM
